Rasagiline is used for relieving symptoms of Parkinson's disease. Since dopamine deficiency may be responsible for many of the symptoms of Parkinson's, rasagiline works by increasing the amount of dopamine the brain can use. There are currently no universally accepted off-label rasagiline uses, and the medication is not approved for use in children.
Rasagiline mesylate (Azilect®) is a Parkinson's disease medication. It belongs to a group of medications known as monoamine oxidase inhibitors (MAOIs). Rasagiline is taken just once a day and is approved to be used alone or in combination with carbidopa-levodopa medications.
What Is Parkinson's Disease?
Parkinson's disease results from the loss of neurons in a region of the brain that controls movement. This creates a shortage of the neurotransmitter (brain-signaling chemical) known as dopamine, causing the movement problems that are characteristic of Parkinson's disease. The exact cause of Parkinson's disease is not currently known.
Although early symptoms of Parkinson's disease may be subtle, people will eventually develop a characteristic tremor (trembling or shaking) of a limb, especially when the body is at rest. As the disease progresses, symptoms may worsen and new ones may appear.
Add this article to your Favorites
Email this article
Print